Find your peptide.
Compare the prices.
Search supplier listings and compare matching vial sizes.
Cagrilintide + Semaglutide
2 suppliers · 4 recorded listings
View strengths, sources and price checks ↗Recognised names group supplier listings. Full supplier labels and formulation differences remain in the details.
| Supplier listing | Size | Price | Price status |
|---|
No matching compounds yet.
Try a different name or explore the current catalogue.
Supplier directory.
Browse suppliers, their published listing counts and direct website links.
How comparisons work.
Choose your market.
Australian listings use AUD. US listings use USD. Switching market selects a different supplier catalogue; it does not convert currency or imply overseas delivery.
Compare like with like.
Rankings use the same compound and vial size. DAC and No DAC, standard and acetylated forms, and different blend ratios stay separate. Ambiguous matches remain unranked.
See the real unit price.
Price per mg is listed vial price divided by supplier-stated mass. For blends, mass is the combined total. It does not measure purity, identity or quality.
Check the original listing.
A product-price button is shown only after its exact product listing is verified. Current rankings use live first-party product-page or catalogue API checks. Cached or imported snapshots remain historical; their actual price-observation dates may be unknown. Shipping, checkout taxes and conditional discounts are excluded unless included in the listing.
An honest timestamp.
Each price has its own check status and date. Website generation never refreshes a price timestamp. Checks older than 24 hours stay visible as overdue and are excluded from current rankings. Suppliers whose latest check failed are hidden from the public catalogue until a successful check. Their records remain stored for audit. A readable supplier with an overdue price may remain listed with its original check date. Each successful check records its own time.
What does “best price found” mean?
The lowest live-checked price among offers that pass the product, formulation, single-vial presentation, size, currency and link checks for the selected market. Checks older than 24 hours and historical prices are excluded. It is not a market-wide guarantee. Rankings use listed prices, not checkout totals.
Why are some offers under review?
A name and total vial mass are not enough to establish a blend ratio or peptide sequence. Those listings can be viewed individually but are excluded from shared best-price rankings.
How is popularity estimated?
When you choose Most popular (estimated), compounds with published US monthly search estimates appear first, highest to lowest. It uses Global Peptide Index’s Ahrefs-based dataset, read by its publisher on 1 October 2026 and checked by Yopepi on 26 October 2026. Equal estimates are ordered by name.
Unmeasured compounds and blends follow, ordered by the number of distinct suppliers in the selected market, then by name. Extra strengths and duplicate offers do not increase that count. We do not infer a blend’s popularity from its ingredients. CJC-1295 interest is a family measure, not a measurement of DAC versus No DAC.
This is an ordering estimate, not sales, Australian search demand, availability, effectiveness or research-use demand. Searches can include medicines, cosmetics and general biology. Missing interest is unknown, not zero. Both market views use the same US interest dataset; supplier coverage is specific to the selected market.
Are suppliers verified?
No supplier quality verification is claimed. A captured listing and a supplier's COA claims do not verify the material a buyer receives. No “Verified Supplier” badges have been issued.
Do you sell peptides or provide dosing advice?
Yopepi compares public research-material listings. Purchases occur on supplier websites. No dosing, administration or personal-use guidance is provided.